Comparison of ESWT and Single-Session 5% Dextrose Prolotherapy in Lateral Epicondylitis
Comparison of the Effectiveness of Extracorporeal Shock Wave Therapy and 5% Dextrose Prolotherapy in Patients With Lateral Epicondylitis: A Prospective Randomized Controlled Trial
1 other identifier
interventional
96
1 country
1
Brief Summary
Lateral epicondylitis is a common musculoskeletal disorder associated with pain and impaired upper extremity function. The aim of this study was to compare the effectiveness of extracorporeal shock wave therapy (ESWT) and single-session 5% dextrose prolotherapy (DPT) in patients with lateral epicondylitis and to evaluate the relative superiority of these treatment approaches during short- and mid-to-long-term follow-up. Ninety-six patients were allocated into three groups: conventional treatment alone, conventional treatment plus ESWT, and conventional treatment plus DPT. Pain, functional status, grip strength, and common extensor tendon thickness were evaluated during follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 29, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 29, 2025
CompletedFirst Submitted
Initial submission to the registry
May 27, 2026
CompletedFirst Posted
Study publicly available on registry
June 2, 2026
CompletedJune 2, 2026
May 1, 2026
1.9 years
May 27, 2026
May 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
VAS Resisted Wrist Extension Pain
Pain during resisted wrist extension assessed using the Visual Analog Scale (VAS).
Baseline, 1 month, 3 months, and 6 months after treatment
VAS Gripping Pain
Pain intensity during gripping assessed using the Visual Analog Scale (VAS).
Baseline, 1 month, 3 months, and 6 months after treatment
VAS Resting Pain
Resting pain assessed using the Visual Analog Scale (VAS).
Baseline, 1 month, 3 months, and 6 months after treatment
VAS Night Pain
Night pain assessed using the Visual Analog Scale (VAS).
Baseline, 1 month, 3 months, and 6 months after treatment
Secondary Outcomes (4)
Quick-DASH Score
Baseline, 1 month, 3 months, and 6 months after treatment
PRTEE Score
Baseline, 1 month, 3 months, and 6 months after treatment
Grip Strength
Baseline and 6 months
Common Extensor Tendon Thickness
Baseline and 6 months
Study Arms (3)
Conventional Treatment + ESWT
ACTIVE COMPARATORThree treatment sessions administered at weekly intervals using 2000 pulses per session at an energy flux density of 0.15 mJ/mm².
Conventional Treatment + Dextrose Prolotherapy
ACTIVE COMPARATORSingle-session ultrasound-guided injection of 1 mL 5% dextrose.
Conventional Treatment
ACTIVE COMPARATORSplinting and home exercise program.
Interventions
Splinting and home exercise program
3 sessions, weekly, 4Hz, 2000 pulses/session, 0.15 mJ/mm².
Single-session ultrasound-guided 1 mL 5% dextrose injection.
Eligibility Criteria
You may qualify if:
- Adults aged 18-75 years
- Clinical and ultrasonographic diagnosis of lateral epicondylitis
- Symptoms persisting for at least 3 months
- Visual Analog Scale (VAS) score ≥4
- Resistance to previous medical treatment
- Ability to comply with study procedures and complete questionnaires
You may not qualify if:
- Injection treatment for lateral epicondylitis within the previous 3 months
- History of trauma within the previous 3 months
- Cervical disc herniation
- Median or ulnar tunnel neuropathy
- Medial epicondylitis
- Anticoagulant therapy use
- Pregnancy or breastfeeding
- Psychiatric disorders or cognitive impairment interfering with questionnaire -completion
- Allergy to the treatment solution
- History of upper extremity surgery or fracture
- Rheumatoid arthritis
- Connective tissue diseases such as dermatomyositis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
SBU Ankara Physical Medicine and Rehabilitation Training and Research Hospital Ankara, Turkey
Ankara, Cankaya, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Physical Medicine and Rehabilitation
Study Record Dates
First Submitted
May 27, 2026
First Posted
June 2, 2026
Study Start
October 1, 2023
Primary Completion
August 29, 2025
Study Completion
August 29, 2025
Last Updated
June 2, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be publicly shared due to institutional and ethical restrictions regarding patient confidentiality.